Drug
Centrum
Centrum is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_3
1
20%
Ph phase_2
3
60%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Not yet recruiting1
Withdrawn1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (20.0%)
Phase 23 (60.0%)
Phase 31 (20.0%)
Trials by Status
not_yet_recruiting120%
withdrawn120%
completed240%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruitingphase_2
PFAS Clinical Trial
NCT07836023
unknownphase_2
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
NCT05536596
withdrawnphase_2
The Role of Antioxidant Supplementation in Keratoconus Patients
NCT02827747
completedphase_3
Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)
NCT00309387
completedphase_1
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
NCT01531790
Clinical Trials (5)
Showing 5 of 5 trials
NCT07836023Phase 2
PFAS Clinical Trial
NCT05536596Phase 2
Pharmacological Treatment on the Recovery of Neurosensory Disturbance After Bilateral Sagittal Split Osteotomy
NCT02827747Phase 2
The Role of Antioxidant Supplementation in Keratoconus Patients
NCT00309387Phase 3
Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)
NCT01531790Phase 1
A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5